Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Uveitis

36,652 views

Published on

Published in: Health & Medicine
  • Free Trial Download 3 week diet http://3weeksdietbest.weebly.com/ The 3 Week Diet is an extreme rapid weight loss program that can help you lose up to 23 pounds of pure body fat in just 3 weeks! Get your customized diet plan ...
       Reply 
    Are you sure you want to  Yes  No
    Your message goes here
  • Njce! Thanks for sharing.
       Reply 
    Are you sure you want to  Yes  No
    Your message goes here
  • Woohoo, guys just came across some IIM A personal interview experiences  http://catking.in/2016/12/20/iim-ahmedabad-personal-interview-experiences/ #TargetIIM #CAT2017 #IIMorNothing 
       Reply 
    Are you sure you want to  Yes  No
    Your message goes here
  • Hello dear, My name is mariam nasrin, I know that this email will meet you in a good health and also surprisingly but God has his own way of bringing people together. Nice to Meet you I would appreciate if you can reply me back( mariamnasrin2@gmail.com ) So that i can explain you more about me. thank Yours mariam.
       Reply 
    Are you sure you want to  Yes  No
    Your message goes here
  • The main focus of treatment is to mitigate the irritation, ease agony, treat basic causes and prevent that could harm vision. Uveitis Treatment duration of time may vary depending on the degree of the disease. http://www.herbs-solutions-by-nature.com/Uveitis.php
       Reply 
    Are you sure you want to  Yes  No
    Your message goes here

Uveitis

  1. 1. Julie Jantzi, O.D. Mallory Cranmer, O.D. Neal Shastri, O.D. Noushin Ahmed, O.D. Seidenberg Protzko Eye Associates
  2. 2. Epidemiology • ~15 per 100,000 in U.S. each year • Causes 10% of blindness in U.S. • Third leading cause of blindness in developed countries • Prevalence varies by location, age, and date of study • Highest among >65 years of age • Females • Chronic and unilateral • Anterior Uveitis most common
  3. 3. Pathophysiology • Inflammation of the uvea • Infectious, traumatic, neoplastic, autoimmune, idiopathic • Inflammatory response: chemical mediators result in vasodilation, increased vascular permeability, and chemotaxis of inflammatory cells in eye.
  4. 4. Inflammatory Cascade Photo Credit: Studyblue.net
  5. 5. Classification Location Duration Type Anterior Uveitis Acute Granulomatous Intermediate Uveitis Chronic Nongranulomatous Posterior Uveitis Panuveitis
  6. 6. Symptoms • Redness • Pain • Photophobia • Epiphora • Blur • Scotoma • Floaters Photo Credit: www.sunglasswarehouse.com
  7. 7. Clinical Signs Anterior to Posterior
  8. 8. Eyelid • Vitiligo • Nodules • Lesions Photo credit: http://www.pcds.org.uk/clinical-guidance/vitiligo
  9. 9. Conjunctiva & Episclera • Ciliary Flush • Diffuse injection Photo credit: http://www.mastereyeassociates.com/eyediseases-treatments/iritis---anterior-uveitis/
  10. 10. Cornea • Keratic Precipitates • Granulomatous • Non-granulomatous • Fibrin • Pigment • Corneal Edema • Band Keratopathy* Photo Credit: http://www.optometricmanagement.com/articleviewer.aspx?artic leid=71765
  11. 11. Anterior Chamber • Cells • Flare (serous) • Pigment • Hypopyon (purulent) • Plasmoid (Fibrinous) • Hyphema + hypopyon (sanguinoid)
  12. 12. Grading
  13. 13. Iris • Nodules • Busacca • Koeppe • Posterior synechiae • Heterochromia • Granulomas • Atrophy (stromal)* • Cyclitic membrane formation*
  14. 14. Angle • Nodule (Berlin) • Vascularization • Peripheral anterior synechiae • Secondary Ciliary body detachment*
  15. 15. IOP • Hypotony • Secondary Glaucoma* (Van Bus-kirk EM: Clinical Atlas of Glaucoma. Philadelphia: WB Saunders, 1986.)
  16. 16. Vitreous • Cells • Flare • Snowball Opacities • Snowbanking • Active • Inactive • Vitreal Strands Photo credit: Mohawk Valley Retina
  17. 17. Retina • Retinal/choroidal inflammatory infiltrates • Sheathing of arteries/veins • Retinal detachment • Schwartz syndrome • RPE hypertrophy/atrophy • Atrophy/swelling of retina, choroid, optic nerve head • Macular edema Photo Credit: Oculist.net
  18. 18. Major Complications • Cataracts • Glaucoma • Band Keratopathy • Cystoid Macular Edema
  19. 19. Differential Diagnoses • Infections • Non-infectious • Masquerade syndromes • Large cell Lymphoma, retinoblastoma, leukemia, malignant melanoma • Juvenile Xanthogranuloma • Pigment dispersion syndrome • Retinal Detachment • Retinitis pigmentosa • Ocular Ishchemic Syndrome
  20. 20. Non-Infectious Uveitis
  21. 21. ANTERIOR UVEITIS: POSTERIOR UVEITIS: • • Collagen Vascular Disease • White Dot Syndromes • Acute nongranulomatous Iritis and Iridocyclitis Chronic Anterior Uveitis PANUVEITIS INTRMEDIATE UVEITIS: • • • • Sarcoidosis Sympathetic Ophthalmia • Vogt-Koyanagi-Harada Syndrome • Behcet Disease Pars Planitis Multiple Sclerosis
  22. 22. Acute Anterior Uveitis HLA-B27 diseases Glaucomatocyclitic crisis Lens associated uveitiis Postoperative inflammation: IOL associated
  23. 23. HLA-B27 DISEASES • Class 1 surface antigen • Seronegative spondyloarthropathies are strongly associated with acute anterior uveitis and HLA-B27 • spondylitis and sacroiliitis Include: • Ankylosing spondylitis • Reactive arthritis syndrome • Inflammatory bowel disease • Psoriatic arthritis
  24. 24. Ankylosing Spondylitis • lower back pain and stiffness • men, 20-40‟s • HLA-B27: 90% • dx: sacroiliac imaging studies - “bamboo spine” Ocular findings (40%): • acute anterior uveitis - fibrin and hypopon not uncommon
  25. 25. Reactive Arthritis Syndrome • Triad: nonspecific urethritis, polyarthritis, and conjunctivitis often accompanied by iritis • HLA-B27: 95%, young adult men • arthritis in knees, ankles, feet, sacroiliitis in 70% of pts Ocular findings: • Mucopurulent and papillary conjunctivits, acute nongranulomatous iritis in 10% Keratoderma blennorrhagicum
  26. 26. Psoriatic Arthritis • Inflammatory arthritis occurs in 30% of pts with chronic psoriasis Inflammatory Bowel Disease • cutaneous changes, distal phalangeal joint inflammation, ungula involvement • • 20% may have sacroiliitis • 25% develop iritis 12% of ulcerative colitis pts and 2.4% of Chrons disease pts develop acute anterior • 20% have sacroiliitis • 60% HLA-B27 positive
  27. 27. Glaucomatocyclitic Crisis • Recurrent unilateral mild acute iritis • Elevated IOP, corneal edema, fine KPs, low-grade cell and flare, slightly dilated pupil • Duration: hours to days • Associated with HLA-B54
  28. 28. Lens-associated Uveitis • • Immune reaction to lens material: granulomatous or nongranulmatous KPs can be small or large, cells mild to severe, hypopon, PS, elevated IOP, vitritis Postoperative inflammation: IOL-associated Mild inflammation to UGH syndrome (uveitis-glaucoma-hyphema) IOL implantation can activate complement cascade, cellular deposits on IOL, synechiae formation, capsular opacification • Retained lens material • Phthisis bulbi, persistent uveitis, or glaucoma often occurs in these eyes • iris chafing caused by the edges or loops of IOL – mechanical irritation and inflammation
  29. 29. Drug Induced Uveitis • Systemic Drugs 1. Rifabutin 2. Bisphosphonates • Topical Drugs 1. Metipranolol 2. Miotics 3. Prostaglandins 3. Sulphonamides 4. Diethylcarbamazine • Intracameral Drugs 1. Cidofovir 5. Cidofovir (intravenous) 2. Antibiotics 3. Urokinase • Vaccines
  30. 30. Chronic Anterior Uveitis Juvenile idiopathic arthritis Fuchs heterochromic iridocyclitis Idiopathic iridocyclitis
  31. 31. • most common systemic disorder associated with iridocyclitis in children • iritis develops within 5-7 yrs of onset of joint disease • RF: female, pauciarticular onset, ANA • negative RF • eye is usually white and uninflamed, some pts do not have pain • Ocular findings: fine KPS, flare and cells, posterior synechiae, cataract, glaucoma, band keratopathy, vitreous debris, ME, chronic hypotony, phthisis Juvenile Idiopathic Arthritis
  32. 32. Fuchs Heterochromic Iridocyclitis • Unilateral uveitis, heterochromia, iris stromal atrophy, small white stellate KPs scattered diffusely over endothelium • synechiae almost never forms but glaucoma and cataracts often occur • Associations with toxoplamosis, HSV, and CMV infections
  33. 33. Idiopathic Iridocyclitis • In many cases of chronic iridocyclitis the cause is unknown
  34. 34. Intermediate Uveitis Pars Planitis Multiple Sclerosis
  35. 35. • absence of infection and systemic disease • 85-90% of intermediate uveitis cases • 5-40 yrs, healthy individuals • associated with HLA-DR15 and HLADR51 alleles Pars Planitis Clinical Characteristics: • 80% bilateral • Ocular manifestations: spillover into anterior chamber, vitreous cells, snowballs, peripheral phlebitis and retinal venous sheathing • Ddx: Syphilis, lyme, sarcoidosis, MS, toxicarasis, lymphoma
  36. 36. Multiple Sclerosis • 30% of MS pts will get uveitis • 15% of pts with pars planitis will eventually develop MS • women, 20-50 yrs • HLA-DR2 and DR15 • Granulomatous anterior uveitis, intermediate uveitis, panuveitis
  37. 37. Posterior Uveitis Collagen Vascular Diseases Inflammatory Chorioretinopathies of Unknown Etiology
  38. 38. Collagen Vascular Disorders Systemic Lupus Erythematosus Polyarteritis Nodosa and Microscopic polyangiitis Wegener‟s Granulomatosis
  39. 39. Systemic Lupus Erythematosus • Multisystem autoimmune connective tissue disorder • Type 3 hypersensitivity reaction: Antibody-immune complexes precipitate and cause further immune response • Affects heart, nervous system, joints, skin, lungs, blood vessels, liver, and kidney • Women, 15-45 years • Labs: ANA • Malar “butterfly” rash -70-80%
  40. 40. Clinical findings Ocular manifestations in 50% • Keratoconjunctivitis sicca (20%) • Lupus retinopathy -CWS • Cutaneous lesions on the eyelids • Scleral inflammatory disease • Neuro-ophthalmic disorders • Retinal vasculopathy • In rare cases uveitis
  41. 41. Polyarteritis nodosa and microscopic polyangiitis • Systemic vasculitis – necrotizing inflammation of medium and small sized arteries • 40-60 yrs, men, hepatitis B • Ocular involvement in 20% • Mortality rate of untreated PAN is 90% by 5 yrs • Labs: p-ANCA, ESR, CRP, tissue biopsy
  42. 42. Wegener‟s Granulomatosis • Triad: necrotizing granulomatous vasculitis of upper and lower respiratory tract, glomerulonephritis, necrotizing vasculitis of small arteries and veins • Involvement of paranasal sinuses is most characteristic feature • Ocular involvement in 50%: -- orbital involvement: pseudotumor, cellulitis, dacryocystitis -- anterior, intermediate, or posterior uveitis --scleritis (necrotizing), uveitis, retinal vascular involvement Dx: tissue biopsy, chest x-ray, CRP, ESR, c-ANCA
  43. 43. White Dot Syndromes • Group of chorioretinopathies that are inflammatory in nature presenting with discrete, multiple, yellow-white lesions • Symptoms: photopsia, blurred vision, floaters, nyctalopia, enlarged blind spot • Young females
  44. 44. • Acute posterior multifocal placoid pigment epitheliopathy (APMPPE) • Birdshot choroidopathy • Multiple evanescent white dot syndrome (MEWDS) • Acute zonal occult outer retinopathy (AZOOR) • Multifocal choroiditis (MCP) • Punctate inner choroidopathy (PIC) • Serpiginous choroiditis
  45. 45. Panuveitis Sarcoidosis Sympathetic Ophthalmia Vogt Koyanagi-Harada Syndrome Behcet Disease
  46. 46. Sarcoidoses • Multisystem non-caseating granulomatous disorder of unknown etiology • Intrathoracic : 90%, intraocular: 50% • Affect lymph nodes, skin, eyes, CNS, bones and joints, liver, and heart • African American, females, 20-50 years • Dx: chest x-ray, lymph node biopsy, elevated ACE and lysozyme levels
  47. 47. Ocular Findings • can involve any ocular tissue • most common: Anterior granulomatous uveitis –mutton fat KP‟s, koeppe and busacca iris nodules, synechiae • Posterior segment in 20% of ocular sarcoidosis --vitreous infiltration “string of pearls” or “snow balls” --granulomas seen in retinal, choroid --perivascular sheathing, occlusive vascular disease • Eyelid granulomas • Conjunctival nodules • Lacrimal gland infiltration
  48. 48. Sympathetic Ophthalmia • Bilateral, diffuse granulomatous, non-necrotizing panuveitis • Autoimmune inflammatory response toward ocular antigens – delayed hypersensitivity to melanin containing structures? • Occurs after surgery or trauma to an eye • 2% of uveitis cases • Anterior Uveitis: mutton fat KPs, PS, thickening of iris from lymphocytic infiltration • Posterior vitritis, dalen-fuchs nodules, peripapillary choroidal lesions, exudative RD
  49. 49. • Cell-mediated autoimmune process driven by T lymphocyctes directed against self-antigens associated with melanocytes of all organ systems • Higher association in darkly pigmented ethnic groups • 4% of uveitis referrals in US • Chronic, bilateral, diffuse, granulomatous panuveitis with integumentary, neurologic, and auditory involvement Vogt-KoyanagiHarada Syndrome
  50. 50. Stages Acute: bilateral granulomatous anterior uveitis, vitritis, thickening of choroid, edema and hyperemia of optic nerve, multiple serous retinal detachments Convalescent: “sunset glow” fundus, skin changes: vitiligo, alopecia, poliosis Chronic recurrent: repeated bouts of uveitis
  51. 51. Behcet Disease • chronic, relapsing, occlusive systemic nongranulomatous vasculitis of unknown etiology • recurrent oral ulcers, skin lesions, genital ulcers, ocular inflammatory disease (70%) • can affect all portions of uveal tract
  52. 52. Ocular Findings 80% bilateral • Anterior uveitis: hypopyon in 25% of cases • Posterior segment: necrotizing retinal vasculitis affects both veins and arteries • Optic nerve affected in 25% of pts • Visual prognosis is guarded -25% VA < 20/200
  53. 53. Infectious Uveitis •Viral – Herpetic, CMV •Fungal •Protozoal - Toxoplasmosis •Helminthic - Toxocara •Bacterial – Syphilis, Lyme, Tuberculosis, other
  54. 54. Viral • Herpes Simplex: • Usually iritis is a keratouveitis but can be: corneal, cutaneous, retinal • arborized • +/- KPs, +/- Hypopyon • HSV-1 is generally oral-labial HSV-2 generally genital infections, although crossover does occur. Image: C. Blake Perry. Source: http://webeye.ophth.uiowa.edu/eyeforum/atlas/pages/HSV-epithelial-keratitis.htm
  55. 55. Viral • Herpes Zoster • • • • 72 hours PHN ¼ ocular involvement Infiltrative pseudodendrites (negative stain) Typically elderly and immunocompromised Image:Yanoff, Myron, and Jay Duker. Ophthalmology. 3rdrd ed. N.p.: Mosby Elsevier, 2009. 223. Print.
  56. 56. • Viral ARN • • • • • • VZV>HSV>CMV Immunocompetent Starts unilateral but 36%Fellow eye Within 6 weeks of onset Painful, Floaters, LOV Peripheral „creamy‟ necrosis that spread, occlusive vascular involvement, Panuveitis • Poor Prognosis, RD in 75% • PORN • VZV mainly • Immunocompromised • Posterior pole involved early • Patchy confluent necrosis, weak or absent uveitis, no vascular involvement • Poor Prognosis, RD in 70% Images: Baumal, Caroline et al. Duane‟s Ophthalmology ,2006.‟Acute Retinal Necrosis and Progresive Outer Retinal Necrosis Syndromes Accessed online: http://www.oculist.net/downaton502/prof/ebook/duanes/pages/v3/v3c028.html#ref
  57. 57. Viral • CMV • • • • • • • CD4 <50-100 Most common opportunistic infection in AIDS In congenital cases + birth defects Before HAART ~30% of CD4<50 After HAART incidence decreased 75-80% May start by looking like CWS (small infiltrates) Perivascular hemorrhages, white necrotic retina, frosted branches /vasculitis Image: Yanoff, Myron, and Jay Duker. Ophthalmology. 3rdrd ed. N.p.: Mosby Elsevier, 2009. 796. Print.
  58. 58. Protozoal • Toxoplasmosis • Toxoplasma gondii • Undercooked meat /cat feces • Most common posterior uveitis in immunocompetent individuals • Often acquired in utero (0.2-1% of pregnancies) • Further Trimester = increased chance of exposure, worst if acquired early (spontaneous abortion) • Majority do not develop ocular manifestations Image: Tabbara. Khalid. „Toxoplasmosis‟. Duane‟s Ophthalmology 2006. Accessed online: http://www.oculist.net/downaton502/prof/ebook/duanes/pages/v4/v4c046.html
  59. 59. Protozoal • Toxoplasmosis • „Headlights in the fog‟ • Focal chorioretinal scar with adjacent necrosis and dense vitritis • With AIDS may have multiple lesions • Often self-resolving over months • May use sulfadiazine, pyramethamine, steroids. Image: Tabbara. Khalid. „Toxoplasmosis‟. Duane‟s Ophthalmology 2006. Accessed online: http://www.oculist.net/downaton502/prof/ebook/duanes/pages/v4/v4c046.html
  60. 60. Helminthic Parasites • Toxocaraisis • Ingesting eggs of Toxocara • Dogs >cats • Acquired through soil, or uncooked food • Particularly affects kids with pica • Yellow white mass with tractional component, may have vitritis. • Often leads to TRD • Treat uveitis, consider anti-helminthics (albendazole) Image: Yanoff, Myron, and Jay Duker. Ophthalmology. 3rdrd ed. N.p.: Mosby Elsevier, 2009. 834. Print.
  61. 61. Bacterial • Syphilis • • • • • • Treponema pallidum „Great Mimicker/Masquerader/Imitator‟ Enters through intact mucosa Ocular Syphilis in 2‟ and 3‟ stages (2-6 mo after) Uveitis most common ocular manifestation (up to 10%) Affects immunocompetent or immunocompromised Image: „Syphilis‟. WebMD. Accessed Online: http://www.webmd.com/sexual-conditions/guide/syphilis
  62. 62. Bacterial • Syphilis • • • • • • • Dilated iris capillaries (iris roseola) Chorioretinitis, „salt and pepper‟ Vasculitis, vitritis, neuroretinitis, CNV, optic neuritis Granulomatous or non-granulomatous uveitis Argyll Robertson Interstitial Keratitis Tests: • Nontreponemal (VDRL / RPR) • Treponemal (FTA-ABS / MHA- TP) • Tx: Penicillin Image: Yanoff, Myron, and Jay Duker. Ophthalmology. 3rdrd ed. N.p.: Mosby Elsevier, 2009. 800. Print.
  63. 63. Bacterial • Lyme • • • • • Borrelia burgdorferi 1: rash (e. migrans) 2: dermatologic, neurologic, cardiac 3: Late arthritis, cranial and peripheral nerves 50% reported no hx of tick bite Image: Sources for Rashes: Poster: "Looking for a Bull's-Eye Rash? Look again - erythema migrans can take many forms. A collaborative effort between the Maryland Department of Health and Mental Hygeine and the Lyme Disease Research Foundation of Maryland Maryland.http://www.bayarealyme.org/get-help/lymes-many-symptoms
  64. 64. Bacterial • Lyme 1. Conjunctivitis early 2.Motility / CN palsies, optic neuropathy, PTC, chorioretinitis, uveitis 3. Stromal keratitis, symblepharon ELISA, Western Immuoblot Tx: Doxycycline, amoxicillin, if needed ceftriaxone Image: Pediatric Associates of Connecticut. „Tick Bites and Lyme Disease, Accessed Online: http://www.pediatricdoc.com/newsletter.cfm?nid=625
  65. 65. Bacterial • Tuberculosis • • • • • • • • • • Mycobacterium tuberculosis Incidence: Annually ~9.3 million patients worldwide Communicable: inhaled aerosolized droplets Primarily involves the lungs Uveitis is common Cough, fever, night sweats Caseating necrotic granulomas CXR PPD / Mantoux testing TB blood tests: interferon-gamma release assays (IGRAs) Images taken from wikipedia . Accessed online: http://en.wikipedia.org/wiki/Tuberculosis_diagnosis
  66. 66. Bacterial • Tuberculosis • • • • Granulomatous anterior, intermediate or posterior uveitis Vasculitis with choroiditis, or choroidal tubercles Phlyctenular conjunctivitis Tx: Rifampin, Isoniazid, Pyrazinamide, Ethambutol Image: Yanoff, Myron, and Jay Duker. Ophthalmology. 3rdrd ed. N.p.: Mosby Elsevier, 2009. 808. Print.
  67. 67. Infectious Endophthalmitis • Endogenous (<10%) • Systemic via blood stream • Organisms causing endocarditis and GI tract are primary sources, usually with sepsis, immunocompromise, IV drug abuse, catheders. • Typically less pain and inflammation, and can be bilateral • Exogenous • • • • Trauma, Surgery, Infection Acutely is usually gram + (normal flora) Decrease in occurrence over the last 30 years. Bleb-associated may occur at any time. • Acute 0.061-0.3% • Delayed 0.2-18% (variable reports) Image taken from „Endophthalmitis‟ by the American Academy of Ophthalmology 2013. Accessed Online: http://www.aao.org/theeyeshaveit/red-eye/endophthalmitis.cfm
  68. 68. Infectious Endophthalmitis • EVS • used <6 weeks, for cataract PO (Acute Onset) • Blur (94%), red eye (82%), pain (74%), hypopyon (86%) • No view of retinal vessels in 79% • Red reflex present in only 32% • Immediate vitrectomy if LP or worse. • B scan • Tx: culture, Vancomycin/Amikacin/Ceftazidime +/Dexamethasone
  69. 69. Masquerade Syndromes Accounts for nearly 5% of all patients with uveitis at tertiary referral. Neoplastic Masquerade • Lymphoma • Uveal melanoma • Retinoblastoma • Juvenile xanthrogranuloma • Metastatic tumors Nonneoplastic Masquerade • Retinitis Pigmentosa • Ocular Ischemic Syndrome • Retinal detachment • Intraocular Foreign Bodies • Pigment Dispersion Syndrome
  70. 70. Lymphoma • 5th to 7th decade of life • 25% ocular involvement • 15% ocular as initial presentation • 56% with ocular involvement develop CNS involvement • Variable uveitic presentations unresponsive to therapy • Can mimic chronic uveitis
  71. 71. Lymphoma: Ocular Findings • Benign reactive uveal lymphoid hyperplasia • Mobile, fleshy episcleral/conj mass • Retinal findings: classic creamy-yellow sub-retinal infiltrates with overlying RPE detachments mimicking sarcoid or birdshot • Anterior uveitis • CME
  72. 72. Lymphoma • Diagnosis • MRI • Cerebrospinal fluid analysis • Tissue diagnosis (definitive method) • Treatment • Intravenous and intravitreal methotrexate • Radiation & IV Cytarabine • >60 years = chemo only • <60 years = combination radiation & chemo • Prognosis = poor
  73. 73. Uveal Melanoma • 5% ocular inflammation • Episcleritis, ant/post uveitis, endophthalmitis Retinoblastoma • 1-3 % with ocular inflammation • White pseudohypopyon • Conjunctival chemosis • Ultrasound: low internal reflectivity • Diffuse infiltrating variant • 4-6 years old • Limited visibility of fundus
  74. 74. Juvenile Xanthogranuloma • Occurs before age 1 • Red-yellow skin lesions • Lesions can involve iris = spontaneous hyphemas • Skin of eyelid involved, globe usually spared • Treatment: topical, periocular, systemic steroids
  75. 75. Metastic Tumors • Adults • • Metastic melanoma: brown spherules in retina Most common: Cutaneous Melanoma • Others: white-yellow • Perivascular sheathing, necrotizing retinitis, retinal vasculitis • Lung, GI, breast • Vitritis, serous detachment, CME • Iris nodules, NVI, high IOP • Anterior uveitis • Bilateral and multifocal • Rare
  76. 76. Nonneoplastic Masquerade • RP • Waxy disc pallor, attenuation of arterioles, bone-spicule mid-periphery • +FHx • Nyctolopia • Vitritis, CME • ERG depressed early Source: http://www.rpfightingblindness.org.uk
  77. 77. Ocular Ischemic Syndrome • Males >65 • CC: decreased vision, mild pain • Corneal edema, A/C reaction, flare>cells, NVI, NVA, • decreased IOP (ischemia), high with NVG • Mild disc edema, dilated tortous veins • mid peripheral hemes • NVD/NVE • FA • Delayed arteriole filling • Diffuse leakage • Capillary non-perfusion • Carotid doppler > 90% diagnostic • Treatment • Endarterectomy • Topical corticosteroids & cycloplegics • PRP for neo • Anti-VEGF injection • 5 year mortality rate of patients 40% • Transient improvement, usually worsens
  78. 78. Retinal Detachment • Chronic Peripheral Rhegmatogenous • AC reaction • Vitreous inflammatory & pigment cells • Good vision, may worsen due to CME • Photoreceptor outer segments may be present in AC simulating inflammatory response • IOP elevated, OAG • Schwartz syndrome • DFE with scleral depression • Peripheral demarcation lines, subretinal fluid, retinal breaks, subretinal fibrosis, peripheral cysts http://gridironforgirls.blogspot.com
  79. 79. Intraocular FB • Chronic inflammation • Mechanical, chemical, toxic, or inflammatory inflammation of ciliary body • Gonio, ultrasound, CT of eye/orbits • Complications: proliferative vitreoretinopathy and endophthalmitis Pigment Dispersion Syndrome • Pigment released from iris and/or ciliary body • Simulates anterior uveitis
  80. 80. Management and Treatment Cycloplegics and mydriatics Corticosteriods Immunomodulating Agents Pressure-lowering medications
  81. 81. Cycloplegics Mydriatics • These opthalmic preparations block the responses of the iris sphincter and the accommodative muscle of the ciliary body to cholinergic stimulation, producing pupillary dilation (mydriasis) and paralysis of accommodation (cycloplegia) • Tropicamide 1%, cyclopentolate and atropine have both properties • Phenylephrine has only mydriasis. www.lookfordiagnosis.com/mesh_info.php?term=
  82. 82. Cycloplegics Purpose: •To break or prevent posterior synechiae and to relieve ciliary spasm induced photophobia. •Short acting vs. long acting cycloplegics •Dosing depends on the extent of inflammation •(1-2xdaily atropine, 3xdaily tropicamide and phenylephrine)
  83. 83. www.opsweb.org/?page=Scien tificExhibit portalcodgdh.minsaude.pt/index.php/Dissecção _ Posterior synechiae
  84. 84. Antigen-dependent lymphocyte activation and STEROID/NSAID activation sites Cunningham, Emmett. Practical approach to the use of corticosteroids in patients with uveitis. Can J Opthalmol 2010; 45:352-8
  85. 85. Corticosteroids: Produced through the hypothalamus, pituitary and adrenal axis (HPA) to control inflammation in uveitis http://pubs.niaaa.nih.gov/publications/arcr 344/images/stephens01.png
  86. 86. Common uses of corticosteroids -Mainstay of initial therapy Cunningham, Emmett. Practical approach to the use of corticosteroids in patients with uveitis. Can J Opthalmol 2010; 45:352-8
  87. 87. Ocular Surface Penetration Durezol>Pred Forte> FML larrazabaleye.com/cvep.html www.revoptom.com/content/c /216 www.revoptom.com/content/c /216 TOPICAL STEROIDS
  88. 88. Topical Steroids Cunningham, Emmett. Practical approach to the use of corticosteroids in patients with uveitis. Can J Opthalmol 2010; 45:352-8
  89. 89. Topical Steroids •Suspension vs. emulsion •Concentration vs. efficacy www.pharmainfo.net/reviews/microemulsionsnovel
  90. 90. Potency Cunningham, Emmett. Practical approach to the use of corticosteroids in patients with uveitis. Can J Opthalmol 2010; 45:352-8
  91. 91. Adverse Effects of Corticosteroids
  92. 92. Adverse Effects continued www.amardeepeyecare.com/ptosis.html
  93. 93. continued www.lpeyecare.com/eyeconditions/252-2
  94. 94. Intravitreal Injections Cunningham, Emmett. Practical approach to the use of corticosteroids in patients with uveitis. Can J Opthalmol 2010; 45:352-8
  95. 95. NSAIDS • www.uninet.edu/cin2001-old/conf/bala/bala.html • www.thedrugmonitor.com/coxi.html
  96. 96. Systemic NSAIDS • Complications of prolonged use: -myocardial infarction -hypertension -stroke (selective Cox-2 inhibitors) www.mayoclinic.com/health/medic www.ohioinjurylaw.com/ohioattorney/medical-mal
  97. 97. Immunomodulating Medications (IMT) • Antimetabolites • T cell signaling Inhibitors • Alkylating Agents • Biologic response modifiers www.riskindoc.com/new_psoria
  98. 98. Indications for IMT  inadequate response of uveitis to corticosteroid therapy for greater than 3 months with doses exceeding 5-10mg/day.  contraindications to corticosteroid use: 1. (diabetes, hypertension, peptic ulcer, GERD, immunocompromised state, psychiatric conditions) 2. exacerbated side effects 3.chronic corticosteroid dependence www.fortiusfitness.com/blog/steroi d-side-effects
  99. 99. Precautions  No infection present  No hepatic or hematologic contraindications  Close physician follow up  Teratogenic mamaprayed.blogspot.com/2012/08/if-you-give-m
  100. 100. Antimetabolites • Azathioprine, methotrexate, mycophenolate mofetil • Azathioprine (purine nucleoside analogue) -interferes with DNA replication and RNA transcription -found beneficial in VKHsyndrome, int. uveitis, Behcet uveitis, sympathetic opthalmia and necrotizing scleritis -GI side effects (nausea, upset stomach) are cause for D/C. -CBC, LFT every 4-6 weeks. -Thiopurine S-methyltransferase (TPMT) testing (metabolizes 6mercaptopurine,ie 6-MP) www.lookfordiagnosis.com/mesh_info.php?term
  101. 101. Methotrexate • Folic Acid analogue • Inhibitor of dihydrofolate reductase and it’s DNA replication • Causes extracellular accumulation of adenosine to create an anti-inflammatory effect. • Useful for JIA (first line choice IMT treatment for children), sarcoidosis, panuveiti s, various other types of uveitis • Prospective study for IV inj. for refractory uveitis and uveitic CME. www.humira.com/jia/what-is-jia.aspx
  102. 102. Mycophenolate Mofetil • Inhibits inosine monophosphate dehydrogenase and DNA replication • Side effects: reversible GI distress, diarrhea; 20%pt. pop. • CBC monthly • 85% effectivity in chronic uveitis patients and a good second choice IMT for children.
  103. 103. T Cell Signaling Inhibitors Cyclosporine and tacrolimus: • Calcineurin inhibitors- disrupt T-cell receptor signal transduction and down regulate IL-2 transcription and CD4 T lymphocyte receptor expression. Sirolimus: • Non-calcineurin inhibitordisrupts T cell signaling that inhibits Ab production and Blymphocytes. www.bdbiosciences.com/research/tcell/reg
  104. 104. Cyclosporine • SE: Nephrotoxicity and systemic hypertension; paresthesia,hypertrichosis. • BP, CBC, serum creatinine monthly. • Used for int. uveitis and posterior uveitis cases from Behcets and VKH. • Used in combination with corticosteroids for modest improvement
  105. 105. Tacrolimus • AE: nephrotoxicity • Low dose and increased potency to cyclosporine • Less risk of hypertension and hyperlipidemia • Useful for chronic int. and posterior uveitis.
  106. 106. Sirolimus • One open-label, prospective study it was found useful in treatment for refractory noninfectious uveitis • GI side effects • Under active investigation for use in treating uveitis
  107. 107. Alkylating Agents Cyclophosphamide • Active metabolites alkylate purines in DNA and RNA, creating impaired DNA replication and cell death • Cytotoxic to dividing and resting lymphocytes • AE:myelosuppression, hemorrhagic cystitis, sterility Chlorambucil • Interferes with DNA replication • AE:myelosuppression, sterility Treatment for int. uveitis, VKH, SO, Behcet Significant AE: increased risk for malignancy (leukemia, various cancers)
  108. 108. Infliximab Biologic Response Modifiers • Chimeric, monoclonal IgG1k antibody against TNFalpha • Treatment for Behcet, sarcoidosis and VKH. Some HLA B27 ant. uveitis • Drug induced toxicity (lupus, systemic vascular thrombosis, CHF, malignancy, demyelinating disease and vitreous hemorrhage) • +PPD, contraindication • Adalimumab, less AE, same effectiveness
  109. 109. Alternative Therapy Under FDA Investigation • Rituximab:chimeric monoclonal antibody against CD20 positive cells (B lymphocytes) • Daclizumab: monoclonal Ab to IL-2 • IFNalpha2a: antiviral, immunomodulatory and antiangiogenic effects (leukopenia and thrombocytopenia side effects)
  110. 110. Management/Follow up • Encounter visit determines extent of ocular inflammation (ant., int., panuveitis, etc). • Make a differential list and send out for further pertinent lab work to confirm/rule out differentials. super-trainer.com/fitness-business-becoming-a-bu
  111. 111. Anterior Uveitis • Cycloplegic • Steroid • Dosage depends on severity • Follow up in 2-3 days • If 2-3 additional follow up appt. prove no improvement, referral to uveitis specialist medlibes.com/entry/anterior-uveitis
  112. 112. Intermediate/Posterior Uveitis • Determine extent of inflammation, if anterior involvement, start on cycloplegic and steroid. • Refer to retinal specialist for periocular steroid injections (if deemed non-infectious) • Intravitreal injections for chronic anterior uveitis or inflammation not responsive to periocular injection www.retinaeye.com/uveitis.html
  113. 113. Uveitic Treatment Adverse Effects • Steroid responders: Need to lower IOP by utilizing beta blockers, alpha2 agonists,CAI, prostaglandins and their combinations where appropriate.
  114. 114. Case #1 • 70+ yr old cauc. male • Redness, mild pain, blurry vision in the right eye. • Slit lamp: 2+ AC WBC reaction; florrid NVI,NVA, corneal edema with descemet folds; IOP 16mmHg OD
  115. 115. Differentials? • Neovascular glaucoma • OIS • PDR
  116. 116. OIS! • DFE: mid-peripheral blot hemorrhages • No CME, NVD, NVE • Tx: Prednisolone Forte q2hrs, Atropine BID OD • Referral to retinal consult for PRP and possible injections of anti-vegf • Contact PCP for carotid doppler, echocardiogram, EKG
  117. 117. Case #2 • 17 yr cauc. female • CC: redness, pain, photophobia, bl urry vision • Review of systems was unremarkable • Second episode, first episode two years ago in GA.
  118. 118. Review of Systems • General - Weight loss, fatigue, fever Skin - Rash, nodules, changes in nails • Neck - Lymphadenopathy • Respiratory - Cough, wheezing • Cardiac - Chest pain/discomfort, dyspnea • Gastrointestinal - Hepatomegaly, diarrhea, frequent bowel movements • Genitourinary - Delayed secondary sexual characteristics • Musculoskeletal - Muscle or joint pain, arthritis, back pain, limitation of motion (refer to uveitis.org for more information and questionnaire)
  119. 119. Differentials? • JIA, lyme disease, lupus, sarcoid • ????? • Ran pertinent lab tests for her age (CBC c diff.,ANA, ACE, Lyme titer,ESR,RF, HLA B27) • Durezol q2hrs, Atropine BID OD. Pledget of 10% phenylephrine to break posterior synechiae • CBC with diff., lyme titre, RF, ANA, ACE, serum lysozyme • Blood results…negative. Consult with uveitis specialist.
  120. 120. Case 3
  121. 121. Chief Complaint • 46 year old WM • Redness OS x 5 days, gradually getting worse that is constant throughout the day • (+) photophobia, epiphora • ( - ) eye pain, flashes, floaters, cold sores • He was seen at Patient First 3 days ago where they diagnosed him with shingles over the left eyelid, noting ocular involvement • Treated with 20 mg Pred, mild pred taper and 1 gm of Valtrex tid x 10 days
  122. 122. History • Medical History • Hypertension, GERD • Treated with Omeprazole and Diovan • Family Medical History • Unremarkable
  123. 123. Examination • VA sc 20/25 OD, OS, OU • OD unremarkable findings • OS • Lid: vesicles along upper forehead & nose, lid erythema, small hordeolum • Conj: nasal injection
  124. 124. Examination • Cornea • Punctate Epithelial Keratitis • Inferior stromal haze • Anterior Chamber • Cells – WBC 2+ • ( - ) Flare • IOP 16, 19 mm Hg • Fundus • Unremarkable OU
  125. 125. Examination • Fundus Unremarkable, OU
  126. 126. Assessment 1. Redness/Discharge of Eye OS 1. Educated patient on findings 2. H. Zoster Keratoconjunctivitis OS 2. Neomycin ung on vesicles, BID 3. H. Zoster Iridocyclitis, OS 3. Pred Forte TID, OS 4. H. Zoster of Eyelid 4. Cool compresses and antibiotic ung on vesicles
  127. 127. Follow Up: 2 days later • Patient now complains of eye pain in the morning • Thinks it is getting worse • Currently taking pred forte tid OS and will finish Valtrex the following week
  128. 128. Examination: 2 days • VA sc 20/25 OD; 20/40 OS PHNI • OD unremarkable • OS Lid: Vesicles along upper forehead & nose with lid erythema, hordeolum on superior lid • Cornea • Prominent pseudodendrites • Anterior Chamber • 2+ WBC • IOP 16, 27 • Fundus: Unremarkable OU
  129. 129. Assessment: 2 days 1. Zoster, Eyelid OS 1. Continue ointment 2. Zoster Iridocyclitis, OS 2. Continue pred forte tid, atropine instilled in office Due to increased IOP: Combigan OS bid RTO 1 week
  130. 130. Follow up: 1 week later • Currently on pred forte TID, Combigan BID, OS only • Finished Valtrex • Feels improvement
  131. 131. Examination: 1 week • VA sc 20/25 OD, 20/40-2 PH 20/25-, OS • OD unremarkable • OS • Lids: healed vesicles, mild ptosis • Conjunctiva: Trace injection • Cornea: Pseudodendrites with endothelialitis inferiorly • Anterior Chamber: 2+ WBC • IOP 17, 20
  132. 132. Assessment: 1 week 1. Redness/discharge of eye OS 1. Injection improved, less tearing 2. H. Zoster of eyelid OS 2. Complete resolution 3. Zoster iridocyclitis 3. Durezol QID, atropine in office (increased IOP); continue combigan BID OS 4. H Zoster keratoconjunctivis 4. Pseudodendrites stable
  133. 133. Follow up 2 weeks later • Patient reports improvement • VA sc 20/30 PH 20/25 OD, OS • OD unremarkable • OS • • • • Lid: no vesicles Conjunctiva: trace injection Cornea: punctate staining Anterior chamber: KP‟s less evident • IOP 16, 18 mm Hg
  134. 134. Assessment: 2 weeks 1. H Zoster Iridocyclitis, OS 1. Improvement with quiet A/C, IOP stable --Continue Combigan BID OS --Taper durezol over 2 weeks, then D/C --RTO 5 weeks
  135. 135. Follow up 5 weeks later • Patient currently on Combigan BID OS only • VA sc 20/25 OD; 20/30 • OD unremarkable • OS • Conjunctiva: tr injection • Cornea: punctate staining • Anterior chamber: NO cells • IOP 16, 18 mm Hg • Assessment • H. Zoster Iridicyclitis • No signs of recurrent inflammation; IOP well • D/C combigan • Follow up 1 month for IOP check
  136. 136. References • Cunningham, Emmett. Practical approach to the use of corticosteroids in patients with uveitis. Can J Opthalmol 2010; 45:352-8 • Moorthy, Ramana. Intraocular Inflammation and Uveitis.American Academy of Opthalmology. Section 9. pgs 98-116. • http://www.uveitis.org/uveitis-questionnaire • http://emedicine.medscape.com/article/1209891-clinical • “Care of the Patient with Anterior Uveitis,” Optometric Clinical Practice Guideline. American Optometric Association.

×